CD45RChighCD4+ intestinal mucosal lymphocytes infiltrating in the inflamed colonic mucosa of a novel rat colitis model induced by TNB immunization.

To clarify the role of CD4(+) intestinal mucosal lymphocytes in chronic intestinal inflammation, we developed a new rat colitis model by immunization with 2,4,6-trinitrobenzenesulfonic acid (TNB) in an emulsion with an adjuvant followed by transrectal administration of a low dose of TNB. Moreover, we assessed the therapeutic effect of anti-CD4 monoclonal antibody (mAb) on this model. In concert with the development ofserum anti-TNB Abs, transmural and segmental colitis that mimics some characteristics of human Crohn's disease was induced in the immunized rats. Immunohistochemical analysis showed the increase of infiltrating lamina propria CD4(+) T cells. Flow-cytometric analysis of isolated cells from inflamed mucosa revealed that CD45RChighCD4(+) T cells were significantly increased. Interestingly, intraperitoneal administration of anti-CD4 mAbs could suppress severe inflammation in the model with decrease of anti-TNB Ab titer. After the treatment with anti-CD4 mAbs, CD45RChighCD4(+) T cells in the lamina propria and interferon-gamma mRNA expression in the colonic lamina propria CD4(+) T cells were decreased. These results indicated that Th1 CD4(+) intestinal mucosal T cells have a role in the progress of inflamed lesions in chronic enteritis. They implicate that a therapy targeting mucosal T cells expressing CD4 may be feasible in the treatment of human Crohn's disease.

[1]  J. Mcghee,et al.  Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance. , 1996, Journal of immunology.

[2]  M. Neurath,et al.  Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. , 1996, Journal of immunology.

[3]  M. Gershwin,et al.  Analysis of function, specificity and T cell receptor expression of cloned mucosal T cell lines in Crohn's disease. , 1996, Journal of autoimmunity.

[4]  Paul C. Rogers,et al.  From Naive to Memory T Cells , 1996, Immunological reviews.

[5]  H. Ishii,et al.  Preferential activation of CD4+V beta 5.2/5.3+ intestinal intraepithelial lymphocytes in the inflamed lesions of Crohn's disease. , 1996, Clinical immunology and immunopathology.

[6]  M. Neurath,et al.  Antibodies to interleukin 12 abrogate established experimental colitis in mice , 1995, The Journal of experimental medicine.

[7]  R. P. Bucy,et al.  Differences in the degree of depletion, rate of recovery, and the preferential elimination of naive CD4+ T cells by anti-CD4 monoclonal antibody (GK1.5) in young and aged mice. , 1995, Journal of immunology.

[8]  H. Ishii,et al.  Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes. , 1995, The Journal of clinical investigation.

[9]  W. Brown,et al.  Enzyme linked immunosorbent assay (ELISA) and immunoprecipitation studies on anti-goblet cell antibody using a mucin producing cell line in patients with inflammatory bowel disease. , 1994, Gut.

[10]  R. Coffman,et al.  Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. , 1993, International immunology.

[11]  J. Watson,et al.  CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells , 1993, The Journal of experimental medicine.

[12]  H. Waldmann,et al.  Control of immune-mediated disease of the central nervous system with monoclonal (CD4-specific) antibodies , 1993, Journal of Neuroimmunology.

[13]  Tamaki Yamada,et al.  A comparative analysis of two models of colitis in rats. , 1992, Gastroenterology.

[14]  T. Bayless,et al.  Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. , 1992, Gastroenterology.

[15]  D. Podolsky,et al.  Inflammatory bowel disease (1) , 1991, The New England journal of medicine.

[16]  M. Capobianchi,et al.  Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon gamma inducers. , 1991, Gut.

[17]  D. Mason,et al.  OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset [published erratum appears in J Exp Med 1991 Apr 1;173(4):1037] , 1990, The Journal of experimental medicine.

[18]  T. Mosmann,et al.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones , 1989, The Journal of experimental medicine.

[19]  J. West,et al.  A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines , 1989, European journal of immunology.

[20]  J. Wallace,et al.  Hapten-induced model of chronic inflammation and ulceration in the rat colon. , 1989, Gastroenterology.

[21]  S. James Remission of Crohn's disease after human immunodeficiency virus infection. , 1988, Gastroenterology.

[22]  M. Hurme,et al.  Induction of TNP-specific cytotoxic T lymphocyte memory in vivo in the absence of T helper cell activity. , 1986, Journal of immunology.

[23]  S. Sriram,et al.  Treatment of established chronic relapsing experimental allergic encephalomyelitis with anti-L3T4 antibodies. , 1986, Journal of immunology.

[24]  M. Brandon,et al.  MRC OX-22, a monoclonal antibody that labels a new subset of T lymphocytes and reacts with the high molecular weight form of the leukocyte-common antigen , 1983, The Journal of experimental medicine.

[25]  S. V. van Deventer,et al.  CD4 antibody treatment in Crohn's disease. , 1992, Scandinavian journal of gastroenterology. Supplement.

[26]  J. Wallace,et al.  Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis. , 1992, Gastroenterology.

[27]  D. Mason,et al.  Lineage relationships and functions of CD4+ T-cell subsets in the rat. , 1991, Research in immunology.